Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $648.8000 (-0.12%) ($648.8000 - $648.8000) on Wed. Nov. 24, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.83% (three month average) | RSI | 50 | Latest Price | $648.8000(-0.12%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN advances 0.2% a day on average for past five trading days. | Weekly Trend | REGN advances 2% a week on average for past two weeks. | Market Behavior | Growth stock rally for large cap. Growth stock rally for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) IBB(52%) DIA(39%) XLV(39%) IWD(38%) SPY(37%) | Factors Impacting REGN price | REGN will decline at least -0.915% in a week (0% probabilities). VIXM(-20%) TBT(-8%) UUP(-7%) VXX(-5%) IGOV(-2%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.915% (StdDev 1.83%) | Hourly BBV | 0 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $649.26(-0.07%) | 10 Day Moving Average | $644.43(0.68%) | 20 Day Moving Average | $637.85(1.72%) | To recent high | -5.2% | To recent low | 19.5% | Market Cap | $68.791b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |